Evolus’ Sandra Beaver Named Orange County Business Journal’s Publi...

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: May 20, 2024

Knight Federal Awarded Prime Contract for Joint Readiness Training Center Support • HILL'S PET NUTRITION PARTNERS WITH ACTRESS AND SENIOR DOG OWNER CECILY STRONG ON NEW CAMPAIGN TO HELP SENIOR PETS AGE BOLDLY • Northern Trust Names Ryan McCauley Senior Managing Director of the Foundation & Institutional Advisors Practice in the West • American Society for Gastroenterology and Endoscopy Launches Artificial Intelligence Institute at Digestive Disease Week • InventHelp Inventors Develop New Storage Ottoman for Children (BDH-291) • Kroger Celebrates Memorial Day with Backyard Grilling Bundle for as Little as $4 per Person • Imagining Combat Without Military Medicine: What Would That Look Like? • Doctors Encouraging More Summer Screen Time for Kids During National Safe Sun Week • 280 Earth, a Company That Removes CO2 From the Air, Announces First Direct Air Capture Plant in Oregon; Closes 50M Series B Fund • American Indian College Fund Launches "Make Native Voices Heard" Voting Campaign • Aramark and Anixter Center Partner on Hiring Event for People with Disabilities • Dion Hinchcliffe joins The Futurum Group, Expanding CIO Strategic Decision-Making Insights and Intelligence Offerings • As You Are Teams Up with Included Health to Increase Access, Expedite Care for Pediatric Patients Suspected to have Autism • Perry Ellis International to Showcase Global Lifestyle Brands at Licensing Expo • Divert, Inc. Announces Harrison, Ohio as the Site of a Future Integrated Diversion & Energy Facility • Werner® Accelerates Sustainability Efforts With Addition of Hydrogen Fuel Cell Truck to Fleet • Pennsylvania Hospitals Become Nonprofit Joining Prime Healthcare Foundation • New Jersey American Water Awards Nearly $1 Million to Support Community Development Projects Across Camden and Salem Cities • ThayerMahan and Ocius sign agreement to produce long-duration USV with acoustic sensor arrays to strengthen AUKUS Pillar II obje • The Toy Association Names Industry Veteran Greg Ahearn as New President & CEO

Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year

NEWPORT BEACH, Calif. , May 10 /Businesswire/ - Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that its Chief Financial Officer, Sandra Beaver, has been awarded Outstanding CFO of a Public Company by the Orange County Business Journal. The award is given to CFOs for outstanding performance as corporate stewards.

Since joining Evolus in 2022, Mrs. Beaver has played a critical role in positioning the company for continued growth and success. In 2023, she supported and led the financial execution of milestones including the company’s licensing agreements which expanded its product portfolio with the addition of late-stage dermal fillers in the U.S. and European markets while broadening the estimated total addressable market by 78% to approximately $6 billion. She also played a significant role in supporting the geographic expansion of the company’s commercial footprint to Austria, Germany, and Italy. Sandra continues to lead the organization to financial success, guiding critical processes to drive smart strategic decisions and broadening the company’s portfolio while maintaining operating expense discipline.

"On behalf of the entire Evolus team, we congratulate Sandra on receiving this well-deserved recognition. In her role as CFO, Sandra’s strong strategic leadership and vision has been instrumental in the success of our Company. Her key insights, exceptional performance and many contributions to our company have guided us through complex business scenarios with seamless precision. Sandra has played a pivotal role in continuing the fast-paced growth of our business, as well as laid the financial pathway to secure a licensing agreement to expand our product portfolio of aesthetic consumer brands,” said David Moatazedi, President and Chief Executive Officer of Evolus.

About Evolus, Inc.

Evolus (NASDAQ: EOLS) is a global performance beauty company evolving the aesthetic neurotoxin market for the next generation of beauty consumers through its unique, customer-centric business model and innovative digital platform. Our mission is to become a global, multi-product aesthetics company based on our flagship product, Jeuveau^® (prabotulinumtoxinA-xvfs), the first and only neurotoxin dedicated exclusively to aesthetics and manufactured in a state-of-the-art facility using Hi-Pure™ technology. Evolus is expanding its product portfolio having entered into a definitive agreement to be the exclusive U.S. distributor of Evolysse™, and the exclusive distributor in Europe of Estyme^®, a line of unique dermal fillers currently in late-stage development. Visit us at www.evolus.com, and follow us on LinkedIn, X, Instagram or Facebook.

Jeuveau^® and Nuceiva^®, are registered trademarks and Evolysse^™ is a trademark of Evolus, Inc.

Hi-Pure^™ is a trademark of Daewoong Pharmaceutical Co, Ltd.

Estyme^® is a trademark of Symatese Aesthetics S.A.S.